Login

Componenta as an Investment - Investor Day 28.11.2022| Sami Sivuranta , CEO of Componenta 00:10:00

Share On Facebook Share On Twitter

Sami Sivuranta is President/CEO/IR at Componenta OYJ.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Spire Mining: Pioneering Mongolia's Coking Coal Industry with Strategic Investments
00:10:00
Talk About Topeka : Financial Insights with Debra Clayton | Debra Clayton - Co-Founder and President of Clayton Wealth Partners
00:10:00
2U CEO Chip Paucek on How His Company is Disrupting Higher Education Forever | Chip Paucek, CEO , 2U Inc.
00:10:00
Trading of Caverion Oyj shares (trading symbol: CAV1V) commenced on the NASDAQ OMX Helsinki Main Market on July 1, 2013.
00:00:00
Dr. Donna Skerrett, CEO, Paradigm Biopharmaceuticals Ltd
00:10:00
Online viralgen new facilities sub-eng sin band 1 | Gustavo Pesquin, CEO, ASKLEPIOS BIOPHARMACEUTICAL, INC.
00:10:00
Virtual Ceremony Marks the Initial Listing of PT Djasa Ubersakti Tbk. on the Indonesia Stock Exchange | Heru Putranto, President, PT Djasa Ubersakti Tbk.
00:10:00
Canada Nickel Company: Driving Growth with a Major Nickel Sulfide Discovery
00:10:00
Innovfest Unbound Collaboration At Core- Forging The Future Of Partnering|Yoram Oron,Founder and General Partner,Vertex Ventures
00:10:00
Insights from a Discussion on Insurance Investments | Woody Bradford, CEO ,Conning.
00:10:00
David Mamet Discusses His Political Transformation on Uncommon Knowledge
00:10:00
Copasa mobilizes and dispatches a team of specialists to Rio to address water-related issues.

© 2017 - Neuhu+